Abstract
Metabolic reprogramming is prevalent in cancer, largely due to its altered chemical environments such as the distinct intracellular concentrations of O<sub>2</sub>, H<sub>2</sub>O<sub>2</sub> and H<sup>+</sup>, compared to those in normal tissue cells. The reprogrammed metabolisms are believed to play essential roles in cancer formation and progression. However, it is highly challenging to elucidate how individual normal metabolisms are altered in a cancer-promoting environment; hence for many metabolisms, our knowledge about how they are changed is limited. We present a novel method, CaMeRe (CAncer MEtabolic REprogramming), for identifying metabolic pathways in cancer tissues. Based on the specified starting and ending compounds, along with gene expression data of given cancer tissue samples, CaMeRe identifies metabolic pathways connecting the two compounds via collection of compatible enzymes, which are most consistent with the provided gene-expression data. In addition, cancer-specific knowledge, such as the expression level of bottleneck enzymes in the pathways, is incorporated into the search process, to enable accurate inference of cancer-specific metabolic pathways. We have applied this tool to predict the altered sugar-energy metabolism in cancer, referred to as the Warburg effect, and found the prediction result is highly accurate by checking the appearance and ranking of those key pathways in the results of CaMeRe. Computational evaluation indicates that the tool is fast and capable of handling large metabolic network inference in cancer tissues. Hence, we believe that CaMeRe offers a powerful tool to cancer researchers for their discovery of reprogrammed metabolisms in cancer.
Introduction
Cancer cells exhibit significant metabolic flexibility, adapting their internal chemistry to thrive in harsh microenvironments characterized by hypoxia, acidity, and oxidative stress. This phenomenon, known as metabolic reprogramming, often involves prioritizing rapid biomass production over energy efficiency—a hallmark exemplified by the Warburg Effect. While the existence of these shifts is well-documented, tracing the specific "rewired" pathways manually is a formidable task.
Existing computational tools for metabolic path-finding frequently rely on "shortest path" algorithms. These assume that biological systems always utilize the most direct route. However, cancer cells often favor specific, non-obvious pathways driven by the overexpression of particular enzymes. There is a critical need for tools that integrate real-world cancer omics data to infer these context-specific metabolic shifts. To address this, we developed CaMeRe (CAncer MEtabolic REprogramming), a web-based tool designed to map these complex biochemical transitions.
Methodology
CaMeRe models the human metabolic landscape as a weighted graph where compounds serve as nodes and enzymatic reactions represent edges. The system integrates structural metabolic templates with large-scale transcriptomic data to provide a cancer-specific view of metabolism.
Data Sources and Graph Construction
The tool utilizes the HumanCyc database to construct a comprehensive template consisting of 2,835 reactions and 3,543 enzymes. To make this network cancer-specific, CaMeRe assigns weights to edges based on gene expression levels derived from The Cancer Genome Atlas (TCGA), which includes data across 33 different cancer types and over 300,000 samples.
Search and Ranking Algorithms
Users provide a starting compound, an ending compound, and a target cancer type. CaMeRe employs a depth-first search (DFS) algorithm to identify all possible paths within a user-defined length. The tool ranks results based on criteria beyond simple path length:
- Bottleneck Enzyme Expression: This ranks pathways based on the expression level of the rate-limiting enzyme, assuming that a pathway is only as functional as its most restricted step.
- Stability (SV): This measures the standard deviation of expression levels across the pathway, favoring routes where all required enzymes are consistently expressed.
Researchers can also upload their own RNA-seq data to compare specific samples against the TCGA baseline, allowing for personalized metabolic inference.
Results and Discussion
Computational evaluation demonstrates that CaMeRe is both accurate and efficient. In tests involving eight well-established cancer metabolic pathways (such as glycolysis and fatty acid oxidation), the tool successfully identified seven (87.5%) within its top three search results. Furthermore, the tool is highly optimized, processing complex queries in an average of 0.6 to 1.5 seconds.
Case Study: Bladder Urothelial Carcinoma (BLCA)
In a validation study using BLCA data, CaMeRe correctly identified the upregulation of key enzymes like GAPDH in glycolysis and GFAT1 in the hexosamine pathway. These findings align with established clinical literature. A key insight from the tool is that metabolic "efficiency" is context-dependent; a pathway ranked highly in a tumor might be ranked very low in normal tissue due to differing enzyme expression profiles.
Limitations and Future Directions
While CaMeRe represents a significant step forward, it has limitations. It currently does not account for metabolite concentrations (e.g., ATP, O<sub>2</sub>) or enzyme kinetics (K<sub>cat</sub> values), which influence reaction directionality and rates. Future iterations aim to incorporate these kinetic parameters and integrate additional databases like KEGG to fill existing gaps in metabolic coverage, such as fatty acid synthesis pathways.
Conclusion
CaMeRe offers a powerful, user-friendly platform for researchers to discover and visualize reprogrammed metabolisms in cancer. By bridging the gap between static metabolic maps and dynamic gene expression data, it provides a more realistic view of the biochemical landscape within a tumor. The tool is publicly accessible at http://csbl.bmb.uga.edu/CaMeRe/.
Summary updated